GBiotech Sarl - Company Review
GBiotech Sarl - Company ReviewSummary
GBiotech Sarl (Geneva Biotech) is a biotechnology company that concentrates on the development of intelligent protein expression technologies. The company offers products in the areas of insect, mammalian, E.Coli and yeast. It also provides custom protein expression vectors construction services and custom protein expression services such as delivery of virus like particles and signal transduction pathways. Geneva Biotech works in collaboration with commercial users through licensing its proprietary technologies. The company also issues licenses for the use of its technologies to commercial users. Geneva Biotech is headquartered in Geneve, Switzerland.
This comprehensive company report of GBiotech Sarl provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.